The FDA determined that N-Nitrosodimethylamine (NDMA) levels in some ranitidine medications "increases over time, and when stored at higher than room temperatures, may result in consumer exposure to unacceptable levels."
The FDA, Environmental Protection Agency (EPA), and the World Health Organization (WHO) all classify NDMA as a cancer-causing substance.
Contact Peoples Coalition today for your free, confidential claim review.